
{"result":[{"lastName":"Kohrt","clinicalFocus":[{"focus":"Oncology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=10873&amp;type=small&amp;showNoImage","displayName":"Holbrook Kohrt","firstName":"Holbrook","href":"http://stanfordhospital.org/profiles/Holbrook_Kohrt","researchInterest":"My research is focused on developing novel therapeutic strategies to enhance anti-tumor immunity. Investigation of preclinical models of bone marrow transplantation and immunomodulatory antibody therapy provides the platform for translation to early phase clinical trials."},{"lastName":"Gotlib","clinicalFocus":[{"focus":"Hematology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4046&amp;type=small&amp;showNoImage","displayName":"Jason Gotlib","firstName":"Jason","href":"http://stanfordhospital.org/profiles/Jason_Gotlib","researchInterest":"My research interests include phase I/II clinical trial evaluation of novel therapies for the following diseases:\r\n--Myelodysplastic syndromes (MDS)\r\n--Chronic myelogenous leukemia (CML)\r\n--Acute myelogenous leukemia (AML)\r\n--Myeloproliferative disorders (MPDs) including:\r\n    Hypereosinophilic syndrome\r\n    Systemic mastocytosis\r\n    BCR-ABL-negative MPDs"},{"lastName":"Pachynski","clinicalFocus":[{"focus":"Genitourinary Cancer"},{"focus":"Oncology"},{"focus":"Immunotherapy"},{"focus":"Prostate Cancer"}],"appointments":[{"appointment":"Instructor,Medicine - Oncology"}],"primaryAppointment":"Instructor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=9589&amp;type=small&amp;showNoImage","displayName":"Russell K Pachynski, MD","firstName":"Russell","href":"http://stanfordhospital.org/profiles/Russell_Pachynski","researchInterest":"The recruitment of key effector immune cells to the tumor microenvironment is critical for improving outcomes in cancer treatment. Our research has focused on evaluation of a novel leukocyte chemoattractant, chemerin. We have shown it can act as a tumor suppressive cytokine by marshaling the host immune system and skewing the number and ratio of key anti-tumor effector cells at the site of tumor. We are continuing our preclinical studies of chemerin, and plan to expand the general approach."},{"lastName":"Levy","clinicalFocus":[{"focus":"Lymphoma "},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Non-Hodgkin's Lymphoma - Medical Oncology"},{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Hodgkin's Disease - Medical Oncology"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Hodgkin's Disease - Hematology"},{"focus":"Oncology (Cancer)"},{"focus":"Non-Hodgkin's Lymphoma - Hematology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Bio-X"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4608&amp;type=small&amp;showNoImage","displayName":"Ronald Levy, MD","firstName":"Ronald","href":"http://stanfordhospital.org/profiles/Ronald_Levy","researchInterest":"Clinical Interests: lymphoma. Research Interests: Immunology and molecular biology of lymphoid malignancy; molecular vaccines for cancer."},{"lastName":"Medeiros","clinicalFocus":[{"focus":"Hematology"},{"focus":"Acute leukemia"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=7743&amp;type=small&amp;showNoImage","displayName":"Bruno Medeiros","firstName":"Bruno","href":"http://stanfordhospital.org/profiles/Bruno_Medeiros","researchInterest":"My clinical activities combine the development of novel therapeutic modalities, translational research activities and epidemiological study of acute leukemia. My special focus is on the development of better, patient tailored therapies for young and elderly patients with acute leukemia."},{"lastName":"Arber","clinicalFocus":[{"focus":"Anatomic/Clinical Pathology"},{"focus":"Hematopathology"},{"focus":"Pathology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=3925&amp;type=small&amp;showNoImage","displayName":"Daniel A. Arber, M.D.","firstName":"Daniel","href":"http://stanfordhospital.org/profiles/Daniel_Arber","researchInterest":"I study molecular genetic and immunophenotypic changes in human hematopoietic neoplasms. These include acute and chronic leukemias, lymphoma, and splenic tumors."},{"lastName":"Liedtke","clinicalFocus":[{"focus":"Multiple Myeloma"},{"focus":"Amyloidosis"},{"focus":"Hematology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Assistant Professor - Med Center Line (By courtesy),Pathology"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Hematology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=6984&amp;type=small&amp;showNoImage","displayName":"Michaela Liedtke","firstName":"Michaela","href":"http://stanfordhospital.org/profiles/Michaela_Liedtke","researchInterest":"1) Design of phase I/II trials for the treatment of Multiple Myeloma and Amyloidosis\r\n\r\n2) Conduct of clinical trials to improve the treatment of patients with acute lymphoblastic leukemia (ALL)\r\n\r\n3) Outcomes research using clinical databases for patients with Multiple Myeloma and Amyloidosis\r\n\r\n4) Characterization of the molecular mechanism of MLL-induced acute leukemia"},{"lastName":"Nakasone","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Medicine"}],"primaryAppointment":"Postdoctoral Research fellow, Medicine","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=36670&amp;type=small&amp;showNoImage","displayName":"Hideki Nakasone","firstName":"Hideki","href":"http://med.stanford.edu/profiles/postdocs/researcher/Hideki_Nakasone","researchInterest":""},{"lastName":"George","clinicalFocus":[],"appointments":[{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Member,Stanford Cancer Institute","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=3926&amp;type=small&amp;showNoImage","displayName":"Tracy I. George","firstName":"Tracy","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Tracy_George","researchInterest":"My interest in translational hematopathology includes systemic mastocytosis and other myeloproliferative neoplasms, laboratory hematology, post-transplant and immunodeficiency-related lymphoproliferative disorders, and reactive lymphadenopathies. I am the pathologist on two clinical trials in treating aggressive types of systemic mastocytosis with an alternative small molecule inhibitor. I chair CAP's Hematology & Clinical Microscopy Resource Committee."},{"lastName":"Link","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Professor,Pediatrics - Hematology & Oncology"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Pediatrics - Hematology & Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4631&amp;type=small&amp;showNoImage","displayName":"Michael Link","firstName":"Michael","href":"http://stanfordhospital.org/profiles/Michael_Link","researchInterest":"Hematology/Oncology, treatment of sarcomas of bone and soft tissue, biology of acute lymphoblastic leukemias, treatment of non-Hodgkin's lymphoma and Hodgkin's disease."},{"lastName":"Sikic","clinicalFocus":[{"focus":"Medical Oncology"},{"focus":"New Drug Studies"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4131&amp;type=small&amp;showNoImage","displayName":"Branimir I. Sikic, M. D.","firstName":"Branimir","href":"http://stanfordhospital.org/profiles/Branimir_Sikic","researchInterest":"Research Interests: cancer pharmacology, mechanisms of resistance to anticancer drugs, regulation and function of MDR1 and tubulin genes, clinical trials of modulation of drug resistance, general oncology, Phase I trials of new drugs, gene expression profiling of cancers"},{"lastName":"Twist","clinicalFocus":[{"focus":"Hematology/Oncology/Stem Cell Transplant,  Pediatric"},{"focus":"Oncology (Cancer), Pediatric"},{"focus":"Pediatric Hematology-Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Pediatrics - Hematology & Oncology"}],"primaryAppointment":"Associate Professor - Med Center Line,Pediatrics - Hematology & Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4366&amp;type=small&amp;showNoImage","displayName":"Clare J. Twist","firstName":"Clare","href":"http://stanfordhospital.org/profiles/Clare_Twist","researchInterest":"My primary research interest is in the study and treatment of neuroblastoma. My clinical interests also include Wilms tumor, hepatoblastoma, post-transplant lymphoproliferative disorders, phase I therapies for hematologic malignancies, as well as  palliative and end of life care."},{"lastName":"Berube","clinicalFocus":[{"focus":"Hemostasis Thrombosis"},{"focus":"Anticoagulation"},{"focus":"Hematology"},{"focus":"Anemia"},{"focus":"Idiopathic thrombocytopenic purpura"},{"focus":"Leukemia - Hematology"},{"focus":"Pregnancy-related hematologic  conditions"}],"appointments":[{"appointment":"Clinical Associate Professor,Medicine - Hematology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Clinical Associate Professor,Medicine - Hematology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=3889&amp;type=small&amp;showNoImage","displayName":"Caroline Berube","firstName":"Caroline","href":"http://stanfordhospital.org/profiles/Caroline_Berube","researchInterest":""},{"lastName":"Laport","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4546&amp;type=small&amp;showNoImage","displayName":"Ginna G. Laport","firstName":"Ginna","href":"http://stanfordhospital.org/profiles/Ginna_Laport","researchInterest":"haploidentical transplantation, follicular lymphoma, adoptive immunotherapy,supportive care"},{"lastName":"Alizadeh","clinicalFocus":[{"focus":"Oncology"},{"focus":"Lymphoma"},{"focus":"B-Cell Chronic Lymphocytic Leukemia"},{"focus":"Waldenstrom Macroglobulinemia"},{"focus":"Burkitt Lymphoma"},{"focus":"Follicular Lymphoma"},{"focus":"Diffuse Large-Cell Lymphomas"},{"focus":"Leukemia, Hairy Cell"},{"focus":"Lymphoma, B-Cell, Marginal Zone"},{"focus":"Hodgkin Disease"}],"appointments":[{"appointment":"Assistant Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Member,Child Health Research Institute"},{"appointment":"Member,Bio-X"}],"primaryAppointment":"Assistant Professor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=9558&amp;type=small&amp;showNoImage","displayName":"Ash A. Alizadeh, MD/PhD","firstName":"Arash","href":"http://stanfordhospital.org/profiles/Arash_Alizadeh","researchInterest":"My research is focused on attaining a better understanding of the initiation, maintenance, and progression of lymphoid tumors, and their response to immunochemotherapy toward improving current treatment strategies.  \r\n\r\nIn this effort, I employ tools from functional genomics, computational biology, molecular genetics, and mouse models.  I hope to apply this knowledge towards the design of clinical trials in the treatment of patients with lymphoma, leukemia, and myeloma."},{"lastName":"Cornbleet","clinicalFocus":[],"appointments":[{"appointment":"Emeritus Faculty-Med Ctr Line,Pathology"}],"primaryAppointment":"Emeritus Faculty-Med Ctr Line,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4109&amp;type=small&amp;showNoImage","displayName":"Phyllis Cornbleet","firstName":"Phyllis","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Phyllis_Cornbleet","researchInterest":"As medical director of the Hematology Laboratory, my main focus is service work, including laboratory administration, bone marrow pathology, and flow cytometry interpretation. Publications arise primarily from development or evaluation of laboratory methods or collections of unusual patient cases."},{"lastName":"Advani","clinicalFocus":[{"focus":"Burkitt's Lymphoma"},{"focus":"Burkitt's Lymphoma - Hematology"},{"focus":"Burkitt's Lymphoma - Medical Oncology"},{"focus":"Hodgkin's Disease"},{"focus":"Investigational Therapeutics"},{"focus":"Leptommeningeal Disease"},{"focus":"Lymphoma "},{"focus":"Mycosis Fungoides"},{"focus":"Non-Hodgkin's Lymphoma"},{"focus":"Oncology (Cancer)"},{"focus":"Plasmacytoma"},{"focus":"Waldenstrom's Macroglobulinemia "},{"focus":"Medical Oncology"}],"appointments":[{"appointment":"Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4018&amp;type=small&amp;showNoImage","displayName":"Ranjana Advani","firstName":"Ranjana","href":"http://stanfordhospital.org/profiles/Ranjana_Advani","researchInterest":"Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas.  Experimental therapeutics with novel chemotherapy and biologically targeted therapies.\r\n\r\nThe research program is highly collaborative with radiation oncology, industry, pathology and dermatology."},{"lastName":"Ganjoo","clinicalFocus":[{"focus":"Oncology"},{"focus":"Soft Tissue Sarcoma"},{"focus":"Gastrointestinal Stromal Tumors"},{"focus":"Ewing's Sarcoma"},{"focus":"Osteosarcoma"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=6696&amp;type=small&amp;showNoImage","displayName":"Kristen N Ganjoo","firstName":"Kristen","href":"http://stanfordhospital.org/profiles/Kristen_Ganjoo","researchInterest":"Non-Hodgkin's Lymphoma;\r\nSoft tissue sarcoma;\r\nOsteosarcoma."},{"lastName":"Weiskopf","clinicalFocus":[],"appointments":[{"appointment":"MD Student, School of Medicine"},{"appointment":"Ph.D., Dean's Office"}],"primaryAppointment":"MD Student, School of Medicine","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=17806&amp;type=small&amp;showNoImage","displayName":"Kipp Weiskopf","firstName":"Kipp","href":"http://med.stanford.edu/profiles/stanfordhospital/researcher/Kipp_Weiskopf","researchInterest":""},{"lastName":"Mitchell","clinicalFocus":[{"focus":"Hematology"}],"appointments":[{"appointment":"Professor,Medicine - Oncology"},{"appointment":"Member,Stanford Cancer Institute"},{"appointment":"Professor,Medicine - Hematology"},{"appointment":"Professor (By courtesy),Chemical and Systems Biology"}],"primaryAppointment":"Professor,Medicine - Oncology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=7064&amp;type=small&amp;showNoImage","displayName":"Beverly S. Mitchell, M.D.","firstName":"Beverly","href":"http://stanfordhospital.org/profiles/Beverly_Mitchell","researchInterest":"Beverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes.   She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials."},{"lastName":"Arai","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"}],"appointments":[{"appointment":"Assistant Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Assistant Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=6161&amp;type=small&amp;showNoImage","displayName":"Sally Arai","firstName":"Sally","href":"http://stanfordhospital.org/profiles/Sally_Arai","researchInterest":"Research interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies."},{"lastName":"Duque Afonso","clinicalFocus":[],"appointments":[{"appointment":"Postdoctoral Research fellow, Pathology"}],"primaryAppointment":"Postdoctoral Research fellow, Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=29334&amp;type=small&amp;showNoImage","displayName":"Atilio Jesus Duque-Afonso","firstName":"Atilio","href":"http://med.stanford.edu/profiles/postdocs/researcher/Atilio_Duque Afonso","researchInterest":""},{"lastName":"Goodnough","clinicalFocus":[{"focus":"Pathology"}],"appointments":[{"appointment":"Professor - Med Center Line,Pathology"},{"appointment":"Professor - Med Center Line,Medicine - Hematology"}],"primaryAppointment":"Professor - Med Center Line,Pathology","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=6160&amp;type=small&amp;showNoImage","displayName":"Lawrence Tim Goodnough","firstName":"Lawrence","href":"http://stanfordhospital.org/profiles/Lawrence_Goodnough","researchInterest":"Dr. Goodnough has a long-standing interest in alternatives to blood therapy.  This includes the concept of antologous blood predonation before elective surgery; acute normovolemic hermodicution;erythropoietic agents to stimulate red blood cell production; pharmacologic strategies to reduce blood loss; artificial oxygen carriers; and re-evaluation of the transfusion trigger.  Publications:                                Goodnough LT:  \"Erythropoietin\", In Scientific Basis of Transfusion Medicine"},{"lastName":"Johnston","clinicalFocus":[{"focus":"Blood and Marrow Transplantation"},{"focus":"Hematology"},{"focus":"Graft-Versus-Host Disease"}],"appointments":[{"appointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation"},{"appointment":"Member,Stanford Cancer Institute"}],"primaryAppointment":"Associate Professor - Med Center Line,Medicine - Blood & Marrow Transplantation","imageUrl":"http://stanfordhospital.org/profiles/viewImage?facultyId=4572&amp;type=small&amp;showNoImage","displayName":"Laura Johnston","firstName":"Laura","href":"http://stanfordhospital.org/profiles/Laura_Johnston","researchInterest":"Clinical research in allogeneic and autologous hematopoietic cell transplantation (HCT), more specifically, allogeneic transplantation and graft versus host disease. Exploring methods of improving prevention and treatment of GVHD as well as the long term follow-up and/or quality of life of affected patients."}]}